The company is dedicated to the field of health medicine, mainly engaged in the research and development of high value-added raw materials and matching pharmaceutical intermediates, process optimization, and innovative drug research in biochemical ligands and subdivisions. The company has a domestic leading technology research and development platform for new pharmaceutical intermediates and APIs, equipped with advanced instruments and equipment, and a complete and accurate analysis and detection system. The company also conducts technology transfer and technical services in subdivided fields. At present, the company has signed a joint R&D laboratory platform co-construction agreement with well-known universities and enterprises across the country to carry out various technical cooperation in an all-round way. The company's pharmaceutical active intermediate products have established cooperative relations with pharmaceutical companies in North America, Europe, Japan, South Korea, India and other regions by virtue of a good product quality control system and competitive prices. Many famous pharmaceutical and R&D companies have cooperation.